Company intelligence / Profile preview

Innovatus Capital Partners

New York City, New York, United Statesinnovatuscp.com ↗

Ownership: Private
Development stage: Other

Overview

Innovatus Capital Partners is an active specialty finance and investment management firm with over $1.5 billion AUM. Its Life Sciences strategy provides growth capital—primarily senior secured debt and some equity—to public and private late-stage development and commercial-stage biotechnology, pharmaceutical, medical device, diagnostic, and life science tools companies. The team has provided approximately $1.5 billion in senior secured debt commitments to leading life sciences firms since 2017. It does not develop drugs or devices itself but enables clinical advancement through its investments.

Industry: Investors

Partnerships

Financing partnerships with Codexis for RNAi therapeutics manufacturing platform developmentPartners with other innovative healthcare/life science firms via lending/investment

Beyond the preview

Go deeper on Innovatus Capital Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innovatus Capital Partners.

Explore the full profile